Whole Genome Sequencing (WGS) Long Read Equipment & Consumables

Tender description

A large-scale Long Read Whole Genome Sequencing (WGS) project using Oxford Nanopore Technologies long read technology in order to evaluate its potential for clinical use in cancer. Lot 1: Genomics England has a Spending Review (SR) objective involving a large-scale long read whole genome sequencing (WGS) project. In order to deliver this long read WGS project Genomics England have engaged and are proposing to partner with Oxford Nanopore Technologies Limited (ONT) to maximise its long read technology at scale to evaluate its potential for clinical use in cancer. This project requires sequencing at scale of around 2,000 germline:tumour pairs over the next 12 month period. A beneficial commercial agreement that represents the unique nature of the engagement in terms of technological development and value has been agreed between the parties to deliver the scope of this project in its entirety. ONT occupy a unique position in the sequencing market globally in terms of read length and throughput technology that makes this project viable. The primary sequencing instrument within this project is the Promethion P48 consuming Flowcell reagents and other associated consumables. A combination of these attributes will deliver the scaling required for the project and the commercial agreement between the parties ensures successful sequencing objectives for clinical use in cancer, within the 12 month SR period.